Novel Recurrently Mutated Genes and a Prognostic Mutation Signature in Colorectal Cancer

Gut - United Kingdom
doi 10.1136/gutjnl-2013-306620
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden

Oncologist
Cancer ResearchMedicineOncology
2018English

Identification and Clinical Validation of a Novel 4 Gene-Signature With Prognostic Utility in Colorectal Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

Frontiers in Oncology
Cancer ResearchOncology
2020English

Radiomics Features of 18f-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer

2019English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

Clinical Impact of Recurrently Mutated Genes on Lymphoma Diagnostics: State-Of-The-Art and Beyond

Haematologica
Hematology
2016English

A Monotonic and Prognostic Genomic Signature From Fibroblasts for Colorectal Cancer Initiation, Progression, and Metastasis

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2014English

A Novel Prognostic Six-CpG Signature in Glioblastomas

CNS Neuroscience and Therapeutics
PsychiatryMental HealthPhysiologyPharmacology
2018English

Novel DNA Variants and Mutation Frequencies of hMLH1 and hMSH2 Genes in Colorectal Cancer in the Northeast China Population

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy